Label: AQUAX- petrolatum, mineral oil cream
- NDC Code(s): 82160-214-01
- Packager: Pella Pharmaceuticals Co. Ltd
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated November 22, 2021
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Forms and presentation
- Active Ingredients
- Inactive Ingredients
- Purpose
- Properties
- Indications
- Contraindications
- Side effects
- Dosage and Administration
- Precaution
- Warnings
- Storage conditions
- Primary Package
- Secondary Package
-
INGREDIENTS AND APPEARANCE
AQUAX
petrolatum, mineral oil creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:82160-214 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PETROLATUM (UNII: 4T6H12BN9U) (PETROLATUM - UNII:4T6H12BN9U) PETROLATUM 75 mg in 150 g MINERAL OIL (UNII: T5L8T28FGP) (MINERAL OIL - UNII:T5L8T28FGP) MINERAL OIL 75 mg in 150 g Inactive Ingredients Ingredient Name Strength CETEARETH-25 (UNII: 8FA93U5T67) CETEARETH-22 (UNII: 28VZG1E234) METHYLPARABEN (UNII: A2I8C7HI9T) ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) WATER (UNII: 059QF0KO0R) POLYSORBATE 80 (UNII: 6OZP39ZG8H) GLYCERIN (UNII: PDC6A3C0OX) CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S) SODIUM CITRATE (UNII: 1Q73Q2JULR) PROPYLPARABEN (UNII: Z8IX2SC1OH) BIS-PEG/PPG-16/16 PEG/PPG-16/16 DIMETHICONE (UNII: 55A74AJ3KB) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:82160-214-01 1 in 1 CARTON 03/25/2010 1 150 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part347 03/25/2010 Labeler - Pella Pharmaceuticals Co. Ltd (562370925)